共 184 条
[1]
Finberg JPM(2014)Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: focus on modulation of CNS monoamine neurotransmitter release Pharmacol Ther 143 133-52
[2]
Gulyás B(2011)Activated MAO-B in the brain of Alzheimer patients, demonstrated by [11C]-L-deprenyl using whole hemisphere autoradiography Neurochem Int 58 60-8
[3]
Pavlova E(2002)Increased monoamine oxidase messenger RNA expression levels in frontal cortex of Alzheimer’s disease patients Neurosci Lett 326 56-60
[4]
Kása P(1994)Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography Neuroscience 62 15-30
[5]
Gulya K(1991)Monoamine oxidase B in brains from patients with Alzheimer’s disease: a biochemical and autoradiographical study Neuroscience 45 1-12
[6]
Bakota L(1990)Expression of monoamine oxidase B activity in astrocytes of senile plaques Acta Neuropathol 80 419-25
[7]
Várszegi S(1995)Selective reduction of radiotracer trapping by deuterium substitution: comparison of carbon-11-L-deprenyl and carbon-11-deprenyl-D2 for MAO B mapping J Nucl Med 36 1255-62
[8]
Emilsson L(2009)Assessment of MAO-B occupancy in the brain with PET and [11C]-L-deprenyl-D2: a dose-finding study with a novel MAO-B inhibitor, EVT 301 Clin Pharmacol Ther 85 506-12
[9]
Saetre P(2012)Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG J Nucl Med 53 37-46
[10]
Balciuniene J(2014)Astrocytosis measured by 11C-deprenyl PET correlates with decrease in gray matter density in the parahippocampus of prodromal Alzheimer’s patients Eur J Nucl Med Mol Imaging 41 2120-6